ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $304 | -99.7% | 1,323 | -97.8% | 0.00% | – |
| Q1 2022 | $90,000 | -28.0% | 60,355 | +5.0% | 0.00% | – |
| Q4 2021 | $125,000 | -44.2% | 57,500 | -8.7% | 0.00% | – |
| Q3 2021 | $224,000 | -41.8% | 62,989 | -6.1% | 0.00% | -100.0% |
| Q2 2021 | $385,000 | +45.3% | 67,116 | +31.5% | 0.00% | – |
| Q1 2021 | $265,000 | +136.6% | 51,024 | +8.4% | 0.00% | – |
| Q4 2020 | $112,000 | +138.3% | 47,070 | +38.3% | 0.00% | – |
| Q3 2020 | $47,000 | -33.8% | 34,040 | -8.2% | 0.00% | – |
| Q2 2020 | $71,000 | +61.4% | 37,098 | +108.1% | 0.00% | – |
| Q1 2020 | $44,000 | +10.0% | 17,830 | 0.0% | 0.00% | – |
| Q4 2019 | $40,000 | +8.1% | 17,830 | 0.0% | 0.00% | – |
| Q3 2019 | $37,000 | -17.8% | 17,830 | -1.1% | 0.00% | – |
| Q2 2019 | $45,000 | – | 18,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |